SCHEMBL7817546

SCHEMBL7817546

CC(C)(Oc1ccc(C2(O)CCN(C(=O)c3ccc(C(F)(F)F)cc3)CC2)cc1)C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 4/20 0.49
PPARA Q07869 4/20 0.49
MEN1 O00255 1/20 0.48
HPGD P15428 1/20 0.48
TSHR P16473 1/20 0.48
KMT2A Q03164 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.47
GPR183 P32249 1/20 0.45
CA12 O43570 3/20 0.45
CA1 P00915 3/20 0.45
CA2 P00918 3/20 0.45
CA7 P43166 3/20 0.45
CA9 Q16790 3/20 0.45
CA14 Q9ULX7 3/20 0.45
CYP3A4 P08684 1/20 0.45
DRD2 P14416 1/20 0.44
KDM4E B2RXH2 1/20 0.44
PPARG P37231 1/20 0.44
PARP10 Q53GL7 2/20 0.44
PARP14 Q460N5 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7813630 0.88 ALDH1A1 (0.51) TSHRSMN1; SMN2CA12CA1CA2
SCHEMBL7814073 0.88 SMN1; SMN2 (0.49) PPARAHPGDSMN1; SMN2CA12CA1
SCHEMBL7809970 0.88 SMN1; SMN2 (0.60) MEN1HPGDTSHRKMT2ASMN1; SMN2
SCHEMBL7813918 0.88 PKLR (0.51) PPARDPPARAMEN1HPGDTSHR
SCHEMBL7817538 0.82 PPARD (0.68) PPARDPPARAMEN1HPGDTSHR
SCHEMBL7811927 0.82 PARP10 (0.53) PPARAHPGDTSHRSMN1; SMN2CA12
SCHEMBL7814142 0.80 SMN1; SMN2 (0.47) PPARAMEN1TSHRKMT2ASMN1; SMN2
SCHEMBL7810110 0.80 HSD11B1 (0.51) PPARDPPARAMEN1HPGDTSHR
SCHEMBL7814122 0.80 SMN1; SMN2 (0.46) PPARAMEN1TSHRKMT2ASMN1; SMN2
SCHEMBL29844006 0.79 MEN1 (0.55) MEN1HPGDTSHRKMT2AGPR183

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0607536-B1 Arylamide derivatives SS PHARMACEUTICAL CO (JP) 2001-01-24 EP disclosed
US-5532371-A SIDE EFFECT REDUCTION SS PHARMACEUTICAL CO., LTD. (JP) 1996-07-02 US disclosed
US-5411972-A Arylamide derivatives for treating hyperlipemia SS PHARMACEUTICAL CO., LTD. (JP) 1995-05-02 US disclosed
EP-0607536-A1 Arylamide derivatives SS PHARMACEUTICAL CO., LTD. (JP) 1994-07-27 EP disclosed